VIQUgim-1SR
Description_Effects
VIQUgim-1SR is a combination medicine containing Glimepiride 1mg and Metformin 500mg in a sustained-release (SR) formulation. It is used in the treatment of type 2 diabetes mellitus, particularly in adults whose blood sugar levels are not adequately controlled by diet and exercise alone. Glimepiride is a sulfonylurea that works by stimulating the pancreas to release more insulin, which helps lower blood sugar levels. Metformin is a biguanide that works in multiple ways: it decreases glucose production in the liver, reduces intestinal absorption of glucose, and improves the body’s sensitivity to insulin. Together, these two medications help maintain steady blood glucose control throughout the day. The SR (sustained-release) formulation allows the medicine to be released slowly into the bloodstream, providing longer-lasting effects with fewer fluctuations in blood sugar. VIQUgim-1SR is generally taken once daily with meals to reduce the chances of stomach upset and to improve glucose absorption. Effective blood sugar control reduces the risk of complications related to diabetes, such as kidney disease, eye problems, nerve damage, and heart disease. For best results, this medicine should be used as part of a complete diabetes management plan that includes a healthy diet, regular physical activity, and routine monitoring of blood sugar levels. Always follow your doctor’s advice when using this medication.
